Global Mofy Enters into Strategic Cooperation with Infinigence AI to Jointly Build an Industrial-Grade AIGC Content Creation Platform
April 8, 2026
Technology
-
-
Quantum-Si Announces First Customer Samples Tested on the Proteus(TM) Prototype System
April 8, 2026
-
Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5-Supported Clinical Activities
April 8, 2026
-
MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy
April 8, 2026
-
Gorilla Technology Receives FCA Approval for Shackleton Finance Acquisition, Paving Way for Launch of Gorilla Tech Capital
April 8, 2026
-
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Operates at Intersection of Life Sciences, Advanced Digital Technologies,
April 8, 2026
-
CEMTREX SUBSIDIARY, INVOCON, SELECTED FOR U.S. NAVY SBIR PHASE I CONTRACT IN NAVAL MINE WARFARE
April 7, 2026
-
TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company’s Runway into Late 2027/Early 2028
April 7, 2026
-
AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards
April 7, 2026
-
Nuvini to Acquire 51% Controlling Stake in the American business of Beyondsoft Corporation, Creating a $148M Global Technology Platform
April 6, 2026
-
Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing
April 6, 2026
-
Quantum-Si Announces the Start of the Proteus(TM) Roadshow
April 6, 2026
-
Mobix Labs: $3.2M Order Received for Technology Used in TSA Airport Scanners
April 6, 2026
-
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
April 3, 2026
-
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026
April 3, 2026
-
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
April 2, 2026